Robert B Ford, Chairman and CEO at Abbott Laboratories, sold ABT on Aug 25, 2026
Data as of Oct 16
- Traded
- Aug 25, 2026
- Disclosed
- Aug 27, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
ABT since disclosure
−6.0%
after the sale
Similar stocks (XLV) since disclosure
+3.0%
XLV — its sector index fund
Change in closing price from Aug 27, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLRobert B Ford Chairman and CEOABT Abbott Laboratories$25.3Mdisclosed Aug 27 · filed 2 days after the trade